SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011830
Filing Date
2021-05-12
Accepted
2021-05-12 16:05:33
Documents
43
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20210331_10q.htm 10-Q 414119
2 EXHIBIT 31.1 ex_247666.htm EX-31.1 11625
3 EXHIBIT 31.2 ex_247667.htm EX-31.2 11626
4 EXHIBIT 32.1 ex_247668.htm EX-32.1 4569
5 EXHIBIT 32.2 ex_247669.htm EX-32.2 4826
  Complete submission text file 0001437749-21-011830.txt   2281432

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pbla-20210331.xml EX-101.INS 353272
7 XBRL TAXONOMY EXTENSION SCHEMA pbla-20210331.xsd EX-101.SCH 28701
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20210331_cal.xml EX-101.CAL 18424
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20210331_def.xml EX-101.DEF 179182
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20210331_lab.xml EX-101.LAB 176435
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20210331_pre.xml EX-101.PRE 197656
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 21915058
SIC: 2834 Pharmaceutical Preparations